Rocket Lab secured an $816 million contract from the U.S. Space Development Agency. The company will build 18 missile defense satellites for its space systems business.
NASA funding cuts and Neutron rocket development challenges continue to impact the long-term outlook. Analysts consider the Neutron program essential for future profitability.
RKLB shares rose 7.03% in today's trading session. This recovery follows a 9.29% drop on February 5. The stock has declined 21.12% over the last 30 days.
The company maintains a total backlog exceeding $1 billion. Shares trade at a 32.2% discount to analyst fair value estimates. Analysts set that fair value target at $97.83. Broader market strength supported the move, with major indices up between 1.7% and 2.2%.